Home
About
Company Profile
Development History
Corporate culture
Product
Electronic materials
Curing type
Accelerator type
Epoxy type
Special Category
Electroplating category
Flame-retardant type
Pharmaceutical intermediate
Cosmetic ingredients
Solution
Qualifications
ISO Quality Management System
Invention patent
Blog
Company News
Industry News
Recruitment
Talent Philosophy
Positions Available
Contact
Step into Yuanshu Pharmaceutical to learn more about our latest developments.
2016.03
The Yuanshu R&D Center has been put into operation.
14
2023
/
12
2015.10
Yuanshu Pharmaceutical Technology Co., Ltd. has been established.
YuanShu Pharmaceutical has successfully obtained an invention patent for a synthetic method of an intermediate compound of a gonadotropin-releasing hormone receptor antagonist.
10
01
YuanShu Pharmaceutical has successfully obtained an invention patent for a new synthetic method of camphoquinone.
[Farshu Invention Patent] A Synthesis Method for an Intermediate of a Gonadotropin-Releasing Hormone Receptor Antagonist
[Yuanshu Invention Patent] A New Synthetic Method for Camphoquinone
Yuan Shu attended the kickoff meeting for the Qixia District’s initiative to enhance quality management system certification among small and micro enterprises.
07
2022
Leaders from the Quality Department of Qixia District and certification experts from Jiangsu Tiangui visited our company to conduct a comprehensive audit and provide guidance on the operation of our quality management system.
04
Yuan Shu Pharmaceutical’s project, “Research and Development of Aromatic Hydrocarbon‑Based Drug Intermediates for Age‑Related Diseases,” has been approved as a proposed key R&D and technological innovation project for Qixia District in 2021.
08
06
YuanShu’s recommended premium product: N,N'-(2-Hydroxy-1,3-propanediyl)di[N-(2-hydroxyethyl)hexadecanamide]
30
03